GUJINJEC
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Guj. Inject (Kerala) do?
Tarajyot Polymers Ltd, a subsidiary of the Government of Kerala, specializes in the production and distribution of pharmaceutical products and medical equipment. They offer a wide range of items including bulk drugs, formulation chemicals, intravenous fluids, and disposable medical instruments.
Who are the competitors of Guj. Inject (Kerala)?
Guj. Inject (Kerala) major competitors are Unick Fix-A-Form, Panjon, Concord Drugs, Vilin Bio Med, ANG Lifesciences, Guj. Terce Lab, Veerhealth Care. Market Cap of Guj. Inject (Kerala) is ₹35 Crs. While the median market cap of its peers are ₹36 Crs.
Is Guj. Inject (Kerala) financially stable compared to its competitors?
Guj. Inject (Kerala) seems to be less financially stable compared to its competitors. Altman Z score of Guj. Inject (Kerala) is 0 and is ranked 8 out of its 8 competitors.
Does Guj. Inject (Kerala) pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Guj. Inject (Kerala) latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Guj. Inject (Kerala) allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Guj. Inject (Kerala) balance sheet?
Guj. Inject (Kerala) balance sheet is weak and might have solvency issues
Is the profitablity of Guj. Inject (Kerala) improving?
Yes, profit is increasing. The profit of Guj. Inject (Kerala) is ₹1.02 Crs for TTM, ₹0.08 Crs for Mar 2024 and ₹0.04 Crs for Mar 2023.
Is the debt of Guj. Inject (Kerala) increasing or decreasing?
Yes, The net debt of Guj. Inject (Kerala) is increasing. Latest net debt of Guj. Inject (Kerala) is -₹0.03 Crs as of Mar-25. This is greater than Mar-24 when it was -₹5.73 Crs.
Is Guj. Inject (Kerala) stock expensive?
Guj. Inject (Kerala) is not expensive. Latest PE of Guj. Inject (Kerala) is 34.49, while 3 year average PE is 129. Also latest EV/EBITDA of Guj. Inject (Kerala) is 32.56 while 3yr average is 89.6.
Has the share price of Guj. Inject (Kerala) grown faster than its competition?
Guj. Inject (Kerala) has given better returns compared to its competitors. Guj. Inject (Kerala) has grown at ~48.57% over the last 1yrs while peers have grown at a median rate of 5.71%
Is the promoter bullish about Guj. Inject (Kerala)?
There is Insufficient data to gauge this.
Are mutual funds buying/selling Guj. Inject (Kerala)?
There is Insufficient data to gauge this.